CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
申请人:MILLENNIUM PHARMACEUTICALS, INC.
公开号:EP1448566A2
公开(公告)日:2004-08-25
[EN] CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF<br/>[FR] ANTAGONISTES DES RECEPTEURS DE LA CHIMIOKINE ET METHODES D'UTILISATION DE CES ANTAGONISTES
申请人:MILLENNIUM PHARM INC
公开号:WO2003045942A2
公开(公告)日:2003-06-05
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.
Esters, Including Triglycerides, and Hydrogen as Feedstocks for the Ruthenium-Catalyzed Direct N-Alkylation of Amines
作者:Rosa Adam、Jose R. Cabrero-Antonino、Kathrin Junge、Ralf Jackstell、Matthias Beller
DOI:10.1002/anie.201603681
日期:2016.9.5
for the direct N‐alkylation of amines with molecular hydrogen for the first time. A broad range of interesting and industrially relevant secondary and tertiary amines are obtained in the presence of an in situ formed Ru/Triphos complex. Notably, plant oil can be efficiently applied in this single‐step process. Moreover, a variety of other methyl esters can be used as N‐alkylationagents in the presence